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Monday, February 22, 2010 255apossible beginning of nucleation. The study has provided a base for continua-
tion of the study of oligomerization and subsequent fibrillation of BLG, which
may provide a fundamental mechanism of formation transferable to other pro-
teins in vivo.
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The formation of insulin amyloid fibrils is important not only for the develop-
ment of reliable drugs and drug delivery systems, but also for modeling the ba-
sic properties of protein self-assembly. Fibrillation kinetics are typically char-
acterized by an initial apparent lag-phase, related to the formation of oligomer,
protofibrils and aggregation nuclei. Afterwards, aggregation proceeds over
a wide range of length scales via fibril elongation, thickening and/or floccula-
tion, and eventual gelation. Here, we focus on the formation of such a gel, made
of insulin amyloid fibrils, upon incubation at high temperature and low pH. By
light scattering and rheological techniques, we monitor the development of the
structural, dynamical and mechanical properties of fibrillar aggregates, up to
the dynamic arrest of the sample and the appearance of a non-ergodic behavior,
which marks the occurrence of gelation. Atomic force microscopy imaging on
incubated samples highlight the existence of a fibrillar network , as well as
a complex hierarchy of different morphologies. Also, small and large angle dy-
namic light scattering experiments clearly show a non-diffusional dynamic be-
havior. Our experiments were able to reveal the structural details hidden in the
apparent lag-phase, displaying the slow fibril nucleation and elongation. We
confirm that this initial stage is followed by an exponential growth of structures
of different sizes. These two kinetic stages of structural growth are mirrored by
the kinetics of the viscoelastic properties and, in particular, by the growth of the
elastic modulus. Our results show that the appearance of a noteworthy elastic
network is associated with the initial fibril nucleation and elongation rather
than with the formation of larger structures which cause the eventual gelation.
1328-Pos
Hybrid Amyloid Fibril Genesis with Components of Sporadic and Familial
Alzheimer’s Disease
Julian Ollesch, Marcus Fa¨ndrich.
Max-Planck Research Unit for Enzymology of Protein Folding, Halle(Saale),
Germany.
Generally, Alzheimer’s Disease (AD) develops spontaneously. Nevertheless,
many families with an inheritable occurrence were identified. Of these, a con-
siderable number shows mutations in the Alzheimer Precursor Protein (APP)
gene concerning regions of the Aß1-40 peptide, as e. g. the ‘‘Flemish’’
A21G [APP A692G] or the ‘‘Iowa’’ mutant D23N[APP D694N]. All except
two of today’s known Aß1-40 mutations in familial AD were reported hetero-
zygously dominant. Therefore, an interaction of wild type (WT) and mutated
(MUT) Aß peptide is likely to occur in the brain of affected patients.
Here we report on the extended co-fibrillation analysis of WT and MUT
Aß1-40 peptide. Thioflavin-T fluorescence data of cofibrillation kinetics indi-
cated a collateral aggregation process, correlated with the MUT:WT ratio.
Coherently, the fibril morphologies of cofibrillates as observed in negative con-
trast transmission electron micrographs also appear to correlate with the
MUT:WT peptide ratio.
We interpret these results that MUT peptide with a preferred fibril conforma-
tion can template the fibril formation of the morphologically pluripotent WT
dose-dependently. This may explain the strain-like symptomatic of different fa-
milial AD cases.
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Islet amyloid polypeptide (IAPP), a hormone co-secreted with insulin by pan-
creatic b-cells, forms amyloids when overexpressed. IAPP amyloids accumu-
late in pancreatic islets and are a hallmark of type-2 diabetes mellitus
(T2DM). Recently, IAPP amyloids were found in kidneys of T2DM patients,
suggesting that IAPP can deposit in organs other than pancreas. Apparently,
the toxic effects to cells are mediated by the preamyloid oligomers. Here, we
investigated whether IAPP preamyloid oligomers are present in the heart in
T2DM. Using immunochemistry, we found significantly increased levels ofIAPP oligomers (by 1853%) in failing hearts from T2DM humans vs. non-di-
abetics and in hearts from T2DM rats transgenic for human IAPP (by
88515%) vs. T2DM rats expressing only rat non-amyloidogenic IAPP. Most
likely, IAPP accumulation in the heart occurs in the pre-diabetic state, when
IAPP is oversecreted in the blood. To investigate the acute effect of IAPP olig-
omers on cardiac function, we incubated isolated rat cardiac myocytes with ex-
ogenous IAPP (5 and 50 mM) for 1-2 h. 50 mM IAPP significantly increased Ca
transient amplitude (by 73519%) in myocytes contracting at 2 Hz. For rapid
screening and analysis of sites susceptible for IAPP accumulation we designed
a noninvasive water proton NMR protocol. We deciphered the magnetic signal
of water surrounding preamyloid oligomers. The variation of this signal was
correlated with population distributions of oligomers and fibrils by using immu-
nochemistry and electron microscopy. We found that embryonic amyloids gen-
erate hyper-intense magnetic signals, which are distinct from hypo-intense
magnetic signals induced by amyloid plaques. These results suggest that
IAPP preamyloid oligomers contribute to cardiac dysfunction in T2DM. Water
proton NMR may prove a useful non-invasive method for detecting these mo-
lecular entities in the heart.
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Protein fiber formation is associated with diseases ranging from Alzheimer’s to
type II diabetes. The fiber formation is a complex reaction, which includes
a number of conformational and oligomeric intermediate states. In recent years,
it has become clear that it is these states, and not the end product (i.e. fibers) of
amyloid formation that are the toxic agents associated with disease. These in-
sights indicate that small molecule screens must to be directed at assembly
mechanism in order to maximize the prospects for success. Islet amyloid poly-
peptide (IAPP) is a 37 residue peptide hormone co-secreted with insulin by the
ß-cells of the pancreas. In patients with type II diabetes, this protein aggregates
as amyloid in a process that is correlated with ß-cell dysfunction and the loss of
ß-cell mass. In in vitro studies, the addition of soluble IAPP has been shown to
be toxic to many ß- and non-ß-cell lines. IAPP fibrillogenesis, as is the case for
many other amylodiogenic proteins, can be catalyzed by lipid bilayers. Para-
doxically, while amyloid fibers are ß-sheet rich, membrane-stabilized states
are a-helical. We have identified a small molecule alpha helix mimetic, IS5,
which inhibits bilayer catalysis of fibrillogenesis, and rescues IAPP-induced
toxicity in cell culture. Importantly, IAPP:IS5 interactions localize to the puta-
tive a-helical region of IAPP, revealing that a-helical states are on pathway to
fiber formation. Normally, IAPP is not amyloidogenic as its cosecreted partner,
insulin, prevents self-assembly. Here, we show that IS5 inhibition is synergistic
with insulin. IS5 therefore represents a new approach to amyloid inhibition as
the target is an assembly intermediate that may additionally restore functional
IAPP expression.
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Human Islet Amyloid Polypeptide (hIAPP) is a highly amyloidogenic protein
found in islet cells of patients with type II diabetes. Because hIAPP is highly
toxic to beta-cells under certain conditions, it has been proposed that hIAPP
is linked to the loss of beta-cells and insulin secretion in type II diabetics.
One of the interesting questions surrounding this peptide is how the toxic
and aggregation prone hIAPP peptide can be maintained in a safe state at the
high concentrations found in the secretory granule where is stored. We show
here through a combination of NMR, ITC, CD, and Thioflavin T fluorescence
that zinc, which is found at millimolar concentrations in the secretory granule,
binds to hIAPPwith a Kd of approximately 100 nM and inhibits hIAPP amyloid
fibrillogenesis in the micromolar range. NMR spectroscopy shows that zinc in-
teracts with hIAPP through coordination to His18 and a probable cation - pi
stacking interaction with Phe15. ITC binding experiments with the rat variant
of IAPP, which lacks His18, indicated an additional binding site with approx-
imately 1 mM affinity. The lower affinity binding site was localized to Arg11
by NMR. The binding of zinc also alters the structure of hIAPP, rigidifying the
N-terminal region of the protein in a near-helical conformation stabilizing the
non-amyloid form of the peptide. The inhibition of the aggregated and toxic
forms of hIAPP by zinc provides a possible mechanism between the recent dis-
covery of linkage between deleterious mutations in the SLC30A8 zinc trans-
porter, which transports zinc into the secretory granule, and type II diabetes.
